Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors

Human immunodeficiency virus (HIV)-infected children and adolescents who are failing antiretrovirals may have a better virologic response when drug exposures are increased, using higher protease inhibitor doses or ritonavir boosting. We studied the pharmacokinetics and safety of high-dose lopinavir-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Robbins, Brian L., Capparelli, Edmund V., Chadwick, Ellen G., Yogev, Ram, Serchuck, Leslie, Worrell, Carol, Smith, Mary Elizabeth, Alvero, Carmelita, Fenton, Terence, Heckman, Barbara, Pelton, Stephen I., Aldrovandi, Grace, Borkowsky, William, Rodman, John, Havens, Peter L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2008
Konular:
Clinical Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533475/
https://ncbi.nlm.nih.gov/pubmed/18625762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00224-08
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller